Department of Pharmacology , Mahatma Gandhi Medical College and Research Institute (MGMCRI), Sri Balaji Vidyapeeth (Deemed-to be-University) , Pondicherry , India
Auto-generated profile, based on publicly available information
Akila Srinivasan
Department of Pharmacology , Mahatma Gandhi Medical College and Research Institute (MGMCRI), Sri Balaji Vidyapeeth (Deemed-to be-University) , Pondicherry , India
Background: Adverse Drug Reactions (ADR) are one of the common causes of hospital admissions and pose a significant clinical and economic burden on the healthcare system. The Adverse Drug Reaction Monitoring Centre (AMC) in JIPMER functioning under the Pharmacovigilance Programme of India (PvPI) plays a vital role in ensuring medication safety by routinely detecting and monitoring ADRs. Hence, this study aimed to assess the characteristics of ADR reported from 2010 to 2020 in AMC JIPMER and to detect signals, if any. Materials and Methods: A total of 6007 ADR reports with a single suspect drug were included for analysis from 2010 to 2020. The characteristics of these reports, including patient’s age and gender, Number and percentage of ADRs, the causality of ADR using WHO UMC (World Health Organization-Uppsala Monitoring Centre) scale, the seriousness of the ADR, and outcome were collected from the ADR reports. MedDRA (Medical Dictionary for Regulatory Activities) Preferred Terms (PT) were used to classify adverse drug reactions. Causality analysis using the Naranjo Algorithm and Preventability using Modified Schumock and Thornton criteria were performed for the ADRs. The number and percentage of severe ADRs were analyzed. The System Organ class of all the ADRs was enumerated. ADRs not mentioned in the US FDA (United States Food and Drug Administration) product label (unlabelled reactions) were documented. Unlabeled reactions with ≥3 ADR reports were included for signal detection by disproportionality analysis. Objective: To study the characteristics of Adverse Drug Reactions (ADR) reported to a regional ADR monitoring center from 2010 to 2020 and to detect signals of disproportionate reporting (SDRs) if any from the reported ADRs. Results: Antineoplastic drugs, followed by antimicrobials, anticonvulsants, Anti snake venom, and NSAID were the most common drugs implicated in ADRs. Skin and subcutaneous tissue disorders were the most common System Organ Class (SOC) involved in the ADRs. Among the 6007 reports, 19.2% were serious ADRs. Most of the ADR reports were of possible causality followed by probable and certain as per WHO UMC and Naranjo causality scales. Only ten ADRs were preventable and one reaction (Tamoxifen-induced neuropathy) was eligible for signal detection. Disproportionality analysis using a 2x2 contingency table showed insignificant signal detection using the Reporting Odds Ratio (ROR) and Proportional Reporting Ratio (PRR). Conclusion: Analysis of ADRs from an ADR Monitoring center functioning in a tertiary care hospital shows antineoplastic drugs to be the most common drugs associated with adverse drug reactions, with rash being the most common adverse effect. The majority of the ADRs were not preventable. No Signals of Disproportionate Reporting (SDR) were detected in our study.
12 May 2026 in Journal of Complementary and Integrative Medicine
Objectives: In this study, the hydroalcoholic extract of entire Begonia malabarica plant was screened to identify its specific phytochemical groups and in vitro cytotoxic potential against HepG2 (Human Hepatocellular carcinoma) cell lines. Methods: Annexin V/PI Apoptotic assay and the MTT assay, were employed in this study. MTT assay was used to evaluate in vitro cytotoxic potential of B. malabarica extract against the HepG2 cell line. The Annexin V/PI Apoptotic assay was performed to estimate the proportion of cells undergoing apoptosis. The results were compared with doxorubicin as standard. Results: The MTT assay found that at highest concentration of 500 μg/mL, the hydroalcoholic extract of B. malabarica reduced cell viability to 24.17 %, while doxorubicin treated cell showed cell viability to 4.8 % at highest concentration of 100 μg/mL. Flow cytometry based Annexin V analysis revealed that B. malabarica extract induced pronounced apoptosis in HepG2 cells, marked by a dominant late apoptotic population (70.56 %) and dead cells (22.17 %), with minimal early apoptotic (0.04 %) and viable cells (7.23 %). The percentage of cells undergone late apoptosis was identical to standard drug doxorubicin (71.2 %). These results suggest a late apoptotic response, potentially involving mitochondrial disruption, oxidative stress, or caspase activation. Conclusions: These findings highlight the presence of bioactive compounds in B. malabarica that can modulate cell death pathways, supporting its potential as a potential anti-cancer agent. However, more research can help in better understanding of the role of this plant as a potential new source of cancer therapy and uncover previously unknown pharmacological activities and properties.